2.3. Treatments with a Pharmacological Inhibitor of Btk or MMP-9 Specific siRNA Targeting Either Endothelial Cells or Neutrophils Causes a Decrease in Alveolar Changes Related to COPD Progression. This evidence concerns the gene BTK and chronic obstructive pulmonary disease.